Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
Xiao, Zhenyu
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma. [electronic resource] - Cancer letters May 2015 - 302-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1872-7980
10.1016/j.canlet.2015.02.036 doi
Animals
Antibodies, Monoclonal--immunology
Antibody Specificity
CD47 Antigen--biosynthesis
Carcinoma, Hepatocellular--immunology
Cell Movement--immunology
Hep G2 Cells
Humans
Liver Neoplasms--immunology
Macrophages--immunology
Male
Mice
Mice, SCID
Phagocytosis--immunology
Xenograft Model Antitumor Assays
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma. [electronic resource] - Cancer letters May 2015 - 302-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1872-7980
10.1016/j.canlet.2015.02.036 doi
Animals
Antibodies, Monoclonal--immunology
Antibody Specificity
CD47 Antigen--biosynthesis
Carcinoma, Hepatocellular--immunology
Cell Movement--immunology
Hep G2 Cells
Humans
Liver Neoplasms--immunology
Macrophages--immunology
Male
Mice
Mice, SCID
Phagocytosis--immunology
Xenograft Model Antitumor Assays